Fierce Healthcare July 23, 2024
Lawmakers bashed the business practices of pharmacy benefit managers during a House Committee on Oversight and Accountability hearing Tuesday.
When they were asked repeatedly about steering patients, increased drug prices and pharmacy closures, the company executives largely refuted claims thrown at them.
Lawmakers were overwhelmingly frustrated with the perceived non-answers given and at one point reminded the leaders of Optum Rx, Express Scripts and CVS Caremark they were under oath. Witnesses at times were united in silence after lawmakers asked questions, knowing they would not provide an answer that would satisfy the members.
The hearing coincided with the release of a new report (PDF) compiled by the committee that found the three largest PBMs — which are vertically integrated with...